NYSE:LH
Laboratory Corp of America Holdings Stock News
$207.67
+1.52 (+0.737%)
At Close: May 10, 2024
LabCorp (LH) Gives Update as Fortrea Spinoff Nears Closure
12:28pm, Monday, 12'th Jun 2023
Fortrea is set to comprise Labcorp's (LH) Clinical Development and Commercialization Services businesses.
LabCorp (LH) Provides Update on Planned Spinoff of Fortrea
02:19pm, Wednesday, 07'th Jun 2023
After separation from LabCorp (LH), Fortrea is set to operate as a global contract research organization that offers comprehensive drug and medical device development services.
LabCorp (LH) Expands Precision Oncology With Biopsy Test
09:49am, Thursday, 01'st Jun 2023
The addition of Labcorp Plasma Focus marks a pivotal step in the expansion of LabCorp's (LH) suite of precision oncology tests.
3 No-Brainer Stocks to Buy in a Correction
06:32am, Friday, 26'th May 2023
NextEra Energy is a utility powerhouse, positioned to keep growing. Laboratory Corp. of America is a leader in diagnostic testing.
Why Is LabCorp (LH) Down 2.7% Since Last Earnings Report?
12:32pm, Thursday, 25'th May 2023
LabCorp (LH) reported earnings 30 days ago. What's next for the stock?
LabCorp (LH) Expands Laboratory Relationship With New Pact
03:52pm, Wednesday, 17'th May 2023
LabCorp's (LH) recent partnership will expand healthcare access, offer advanced diagnostic tools and guarantee that both patients and doctors can afford the treatments they get.
Here's Why Investors Should Retain LabCorp (LH) Stock for Now
03:57pm, Tuesday, 16'th May 2023
Investors are optimistic about LabCorp (LH) on strategic partnerships and upbeat guidance.
LabCorp (LH) Base Business Growth Strong, Margin Pressure Stays
12:11pm, Tuesday, 16'th May 2023
LabCorp (LH) is progressing well with its planned spin-off of the Clinical Development business, which is expected to be completed in mid-2023.
Laboratory Corporation of America Holdings (LH) Q1 2023 Earnings Call Transcript
03:56pm, Tuesday, 25'th Apr 2023
Laboratory Corporation of America Holdings (LH) Q1 2023 Earnings Call Transcript.
LabCorp (LH) Q1 Earnings Miss Estimates, Margins Decline
01:40pm, Tuesday, 25'th Apr 2023
The decline in COVID-19 PCR and antibody testing sales, the severe foreign exchange headwind and inflationary pressure hurt LabCorp's (LH) business performance in Q1.
LabCorp (LH) Misses Q1 Earnings Estimates
09:09am, Tuesday, 25'th Apr 2023
LabCorp (LH) came out with quarterly earnings of $3.82 per share, missing the Zacks Consensus Estimate of $3.99 per share. This compares to earnings of $6.11 per share a year ago.
7 Low-PE Ratio Blue-Chip Stocks Offering Both Quality and Value
07:32pm, Wednesday, 19'th Apr 2023
While the concept of acquiring low-PE ratio blue-chip stocks (that is, industry-leading stalwarts that feature low price-earnings ratios relative to their sectors) appeals on paper, investors need to
8 Defensive Plays as Healthcare Stocks Stumble
11:13am, Wednesday, 19'th Apr 2023
Healthcare stocks have sputtered this year after performing well in 2022. A Barron's screen has identified stocks that are poised to outperform for the rest of the year.
LabCorp (LH) Expands Colon Cancer Test Access With New Pact
01:42pm, Tuesday, 04'th Apr 2023
LabCorp's (LH) at-home collection kit will offer patients an additional and easier option to get screened for colon cancer.
Labcorp to pay $2.1 million to settle allegations it overbilled Defense Department for genetic tests for military members
03:08pm, Monday, 27'th Mar 2023
A former Labcorp employee turned whistleblower sued the diagnostic testing company in 2018 on behalf of the federal government under the False Claims Act.
